Uniqus Consultech Onboards UST as an Investor, as Part of its Previously Announced Series B Round
Reading Time: 3 minutes Aliso Viejo, Calif., United States & Mumbai, Maharashtra, India: UST, a leading digital transformation solutions company, has invested in Uniqus Consultech, a tech-enabled global platform that offers consulting solutions in the accounting & reporting, finance operations, governance, risk, ESG, and technology
Invest in Bogota Seeks New Investment Opportunities at Bengaluru Tech Summit 2024
Reading Time: 2 minutes From November 19 to 21, Invest in Bogota, the investment promotion agency of Colombia’s capital, will participate in the Bengaluru Tech Summit 2024, one of the world’s leading events for the global tech ecosystem. This year’s summit will feature over 400 speakers, including
BioStock: BiBBInstrument’ founder on the Sahlgrenska evaluation
Reading Time: < 1 minute Tue, Nov 19, 2024 08:15 CET Report this content BiBBInstruments takes another step in the clinical evaluation of EndoDrill GI. Recently, Sahlgrenska University Hospital in Gothenburg joined the growing group of clinics evaluating the instrument. BioStock contacted the
Synsam Group’s Q3 report 2024
Reading Time: 5 minutes Continued organic growth by consistent strategy execution 1 July – 30 September 2024 Net sales increased to SEK 1,559 million (1,450), up 7.6 percent. Organic growth totalled 9.5 percent (7.0) Net sales from spectacles subscriptions increased 11.0 percent (13.7) The gross
Guidewire Outlines Vision for How Modern Core Platforms will Unlock a New Era of Efficiency and Effectiveness in P&C Insurance
Reading Time: 6 minutes Nashville, Tenn., United States: CONNECTIONS CONFERENCE – Guidewire (NYSE: GWRE) will showcase its commitment to improving risk selection and pricing, indemnity management, and claims efficiency in property and casualty insurance at its annual customer conference, Connections. The event will unveil future
Lytix Biopharma Q3 2024: Positive clinical results and strategic advancements strengthen path to commercialization
Reading Time: 3 minutes Oslo, 19 November 2024. Lytix Biopharma (“Lytix”) (Euronext Growth Oslo: LYTIX), a Norwegian immuno-oncology company dedicated to being part of tomorrow’s cancer treatment, today releases its third quarter 2024 results. Lytix achieved substantial progress in its clinical pipeline, progressing towards
HistoSonics® Enrolls First Patients in Company’s Novel BOOMBOX Master Study
Reading Time: 4 minutes MINNEAPOLIS, United States: HistoSonics, the developer and manufacturer of the Edison® Histotripsy System, announced today the first patients were enrolled in their novel prospective master protocol study, called BOOMBOX, designed to evaluate the real-world use of histotripsy for treatment of liver
Effective Ways to Save Money on Your Utility Bills in Time For Winter
Reading Time: 6 minutes As the colder months approach, it is crucial to take some steps now to reduce your energy consumption and lower your utility bills. By implementing a few simple strategies, you can significantly reduce your energy costs and contribute to a
#24-395 Listing of Derivatives at NGM
Reading Time: < 1 minute Information about various derivatives that will be listed at NGM. For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGM Nordic Growth Market
#24-396 Delisting of Derivatives from NGM
Reading Time: < 1 minute Information about certain derivatives that will be delisted from NGM. For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGM Nordic Growth Market